{"id":"https://openalex.org/W3083179954","doi":"https://doi.org/10.1158/1538-7445.am2020-5547","title":"Abstract 5547: Synergistic action of sitagliptin and checkpoint inhibition for ovarian cancer therapy","display_name":"Abstract 5547: Synergistic action of sitagliptin and checkpoint inhibition for ovarian cancer therapy","alternate_titles":[],"publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083179954","doi":"https://doi.org/10.1158/1538-7445.am2020-5547","mag":"3083179954"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-5547","doi":"https://doi.org/10.1158/1538-7445.am2020-5547","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5547","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3083179954"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089827645","display_name":"Laura R. Moffitt","orcid":"https://orcid.org/0000-0003-4496-2263","observed_orcids":["https://orcid.org/0000-0003-4496-2263"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Laura R. Moffitt","raw_affiliation_strings":["1Monash University, Clayton, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Monash University, Clayton, Australia;","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Amy L. Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802600346","display_name":"Hudson Institute of Medical Research","ror":"https://ror.org/0083mf965","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I2802600346"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Amy L. Wilson","raw_affiliation_strings":["2Hudson Institute of Medical Research, Clayton, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hudson Institute of Medical Research, Clayton, Australia;","institution_ids":["https://openalex.org/I2802600346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091463938","display_name":"Bashirah Basri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I82951845","display_name":"RMIT University","ror":"https://ror.org/04ttjf776","country_code":"AU","type":"education","lineage":["https://openalex.org/I82951845"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Bashirah Basri","raw_affiliation_strings":["3RMIT University, Bundoora, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3RMIT University, Bundoora, Australia","institution_ids":["https://openalex.org/I82951845"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008102725","display_name":"Kirsty Wilson","orcid":"https://orcid.org/0000-0001-7679-9611","observed_orcids":["https://orcid.org/0000-0001-7679-9611"]},"institutions":[{"id":"https://openalex.org/I82951845","display_name":"RMIT University","ror":"https://ror.org/04ttjf776","country_code":"AU","type":"education","lineage":["https://openalex.org/I82951845"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kirsty L. Wilson","raw_affiliation_strings":["3RMIT University, Bundoora, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3RMIT University, Bundoora, Australia","institution_ids":["https://openalex.org/I82951845"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070150682","display_name":"Magdalena Plebanski","orcid":"https://orcid.org/0000-0001-6889-3667","observed_orcids":["https://orcid.org/0000-0001-6889-3667"]},"institutions":[{"id":"https://openalex.org/I82951845","display_name":"RMIT University","ror":"https://ror.org/04ttjf776","country_code":"AU","type":"education","lineage":["https://openalex.org/I82951845"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Magdalena Plebanski","raw_affiliation_strings":["3RMIT University, Bundoora, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3RMIT University, Bundoora, Australia","institution_ids":["https://openalex.org/I82951845"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111759385","display_name":"Andrew N. Stephens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802600346","display_name":"Hudson Institute of Medical Research","ror":"https://ror.org/0083mf965","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I2802600346"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew N. Stephens","raw_affiliation_strings":["2Hudson Institute of Medical Research, Clayton, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hudson Institute of Medical Research, Clayton, Australia;","institution_ids":["https://openalex.org/I2802600346"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"5547","last_page":"5547"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6791999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6791999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.29490000009536743,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8619999885559082},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.8790000081062317},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.921999990940094},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/effector-cd8-t-cells","display_name":"CD8+ effector T cells","score":0.6919999718666077},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8259999752044678},{"id":"https://openalex.org/keywords/peritoneal-cavity","display_name":"peritoneal cavity","score":0.7409999966621399},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7940000295639038},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7608041167259216},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7218186259269714},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.720954954624176},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5173398852348328},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48892322182655334},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4770295321941376},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4681420922279358},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3763442039489746},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32444795966148376},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.1007741391658783},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-5547","doi":"https://doi.org/10.1158/1538-7445.am2020-5547","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-5547","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3121271462","https://openalex.org/W3106557521","https://openalex.org/W1414458693","https://openalex.org/W4387135350","https://openalex.org/W7170141121","https://openalex.org/W2623412210","https://openalex.org/W3197511191","https://openalex.org/W4392817273","https://openalex.org/W2338354566","https://openalex.org/W2624198149"],"abstract_inverted_index":{"Abstract":[0],"Ovarian":[1,84],"cancer":[2,38,99,319,348],"is":[3,41],"the":[4,69,102,157,193,232,240,268,283,354,358],"most":[5],"lethal":[6],"gynecological":[7],"malignancy":[8],"and":[9,129,161,168,181,212,289,310,343,368],"treatment":[10,150,229],"options":[11],"have":[12,20,29],"not":[13],"improved":[14],"in":[15,54,81,88,156,239,275,300],"decades.":[16],"Whilst":[17],"ovarian":[18,37,82,98,276,301,318,347],"tumors":[19,85,106],"an":[21,42,63,73,165],"immune-mediated":[22],"component,":[23],"emerging":[24],"immunotherapies":[25],"(e.g.":[26],"anti-PD-1,":[27],"anti-PD-L1)":[28],"failed":[30],"to":[31,45,50,133,143,208,258,296,314],"achieve":[32],"robust":[33],"clinical":[34],"response":[35],"for":[36,139,254,317,346,361],"patients.":[39,320],"There":[40],"urgent":[43],"need":[44],"develop":[46],"new":[47],"therapeutic":[48],"strategies":[49],"improve":[51,315],"survival":[52,141,203],"rates":[53],"women,":[55],"particularly":[56],"those":[57],"with":[58,198,287],"recurrent,":[59],"chemoresistant":[60],"disease.":[61,173],"In":[62],"ongoing":[64,279],"study":[65],"we":[66,262],"are":[67,251,281],"investigating":[68,282],"repurposing":[70],"of":[71,95,104,115,192,234,270,285,341,353,357],"sitagliptin,":[72],"anti-diabetes":[74],"drug,":[75],"as":[76,146,214,292],"a":[77,111,189,217,293,307],"novel":[78],"immunomodulatory":[79],"therapy":[80,349],"cancer.":[83],"were":[86,124,137,188],"generated":[87],"C57BL/6":[89],"wild-type":[90],"mice":[91,109],"by":[92,126,205,221],"intrabursal":[93],"implantation":[94],"ID8":[96],"murine":[97],"cells.":[100],"Following":[101],"formation":[103],"primary":[105],"(~2":[107],"weeks),":[108],"received":[110],"daily":[112],"oral":[113],"dose":[114],"sitagliptin":[116,149,199,228,265,286,342],"(50mg/kg)":[117],"until":[118],"ethical":[119],"endpoint.":[120],"Anti-tumor":[121],"immune":[122,195,223,255,271],"responses":[123],"examined":[125],"flow":[127],"cytometry":[128],"immunohistochemical":[130],"staining":[131],"according":[132],"tumor":[134,162],"stage.":[135],"Mice":[136],"assessed":[138],"overall":[140],"compared":[142,207],"paclitaxel":[144,213],"chemotherapy":[145],"standard-of-care.":[147],"Daily":[148],"increased":[151,185,201,231],"circulating":[152],"Teff:Treg":[153,186],"cell":[154,179],"ratios":[155,187],"blood,":[158],"peritoneal":[159,241],"fluid":[160],"tissue":[163],"at":[164],"early":[166],"stage,":[167],"this":[169],"was":[170],"sustained":[171],"throughout":[172],"Sitagliptin":[174],"also":[175],"enhanced":[176],"T":[177,236,249],"effector":[178,237],"activation":[180],"proliferation,":[182],"indicating":[183],"that":[184,247,264],"positive":[190],"indicator":[191],"anti-tumor":[194,222],"response.":[196],"Treatment":[197],"alone":[200],"median":[202],"time":[204],"27%":[206],"both":[209],"untreated":[210],"controls":[211],"standard-of-care,":[215],"suggesting":[216],"beneficial":[218],"effect":[219],"mediated":[220],"responses.":[224],"Of":[225],"particular":[226],"interest,":[227],"specifically":[230],"percentage":[233],"CXCR3+":[235,248],"cells":[238,250],"cavity.":[242],"Recent":[243],"data":[244],"has":[245],"suggested":[246],"functionally":[252],"required":[253],"checkpoint":[256,272,344],"inhibitors":[257],"exert":[259],"efficacy.":[260],"Thus,":[261],"hypothesize":[263],"may":[266],"enhance":[267],"efficacy":[269,299],"inhibitor":[273],"therapies":[274],"cancers.":[277,302],"Our":[278],"studies":[280,304],"combination":[284],"anti-PD-1":[288],"anti-PD-L1":[290],"antibodies,":[291],"rational":[294],"approach":[295,313],"improving":[297],"their":[298],"These":[303],"will":[305],"identify":[306],"clinically":[308],"relevant":[309],"directly":[311],"translatable":[312],"prognosis":[316],"Citation":[321],"Format:":[322],"Laura":[323],"R.":[324],"Moffitt,":[325],"Amy":[326],"L.":[327,332],"Wilson,":[328,333],"Bashirah":[329],"Basri,":[330],"Kirsty":[331],"Magdalena":[334],"Plebanski,":[335],"Andrew":[336],"N.":[337],"Stephens.":[338],"Synergistic":[339],"action":[340],"inhibition":[345],"[abstract].":[350],"In:":[351],"Proceedings":[352],"Annual":[355],"Meeting":[356],"American":[359],"Association":[360],"Cancer":[362,374],"Research":[363],"2020;":[364],"2020":[365],"Apr":[366],"27-28":[367],"Jun":[369],"22-24.":[370],"Philadelphia":[371],"(PA):":[372],"AACR;":[373],"Res":[375],"2020;80(16":[376],"Suppl):Abstract":[377],"nr":[378],"5547.":[379]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3083179954","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-09-11T00:00:00"}
